Brookfield Renewable vs Revvity Inc — how do they compare? Brookfield Renewable trades at $28.28 (market cap $8.75B), while Revvity Inc trades at $150.89 (market cap $15.86B). The key difference: Revvity Inc is the larger of the two by market cap, and Brookfield Renewable pays the higher dividend (5.39%). Which is the better fit depends on your goals.
| BEP | RVTY | |
|---|---|---|
Market Cap | $8.75B | $15.86B |
Volume | 833,952 | 2,244,322 |
Sector | Utilities | Health |
52-Week High | $37.31 | $146.73 |
52-Week Low | $25.52 | $82.26 |
Enterprise Value | $43.35B | $18.18B |
Dividend Yield | 5.39% | 0.2% |
Typical Hold Time | — | 11 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $147.02, up 2.59% today, and is approaching its 52-week high. The stock shows a bullish technical trend with strong moving average signals, though the RSI suggests mild overbought conditions. Fundamentally, the company maintains solid profitability with a 54.98% gross margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal announced on September 9, 2026, to expand its metabolic disease research tools.
The outlook for RVTY is positive, supported by earnings momentum and strategic growth initiatives, but the stock's premium valuation (P/E of 68.32) poses a risk if growth slows. Analyst consensus is bullish with a $124 price target, though the current price exceeds this, indicating potential near-term consolidation. Key risks include execution challenges in integrating acquisitions and competitive pressures in the healthcare sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Brookfield Renewable owns and operates renewable power and sustainable solutions businesses. Its portfolio includes hydroelectric, wind, solar, distributed energy, and energy storage assets.
Read more on BEP →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →